SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
The Ethics and Economics of Pharmaceutical Pricing
16 references·0 citing·44 second hop
The Ethics and Economics of Pharmaceutical Pricing (2014)The Ethics and Economics of Pharmaceutica…Intellectual Property Rights and Innovation: Evidence from the Human Genome (2013)Intellectual Property Rights …The Case Against Patents (2012)The Case Against PatentsEvergreening, patent challenges, and effective market life in pharmaceuticals (2012)Evergreening, patent challeng…The Empirical Impact of Intellectual Property Rights on Innovation: Puzzles and Clues (2009)The Empirical Impact of Intel…Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis (2008)Medicine prices, availability…Against Intellectual Monopoly (2008)Against Intellectual MonopolyPhysician Awareness of Drug Cost: A Systematic Review (2007)Physician Awareness of Drug C…Social entrepreneurship: Creating new business models to serve the poor (2004)Social entrepreneurship: Crea…UNCERTAINTY AND THE WELFARE ECONOMICS OF MEDICAL CARE (2003)UNCERTAINTY AND THE WELFARE E…Differential Pricing for Pharmaceuticals: Reconciling Access, R&D and Patents (2003)Differential Pricing for Phar…The Importance of the Physician in the Generic versus Trade-Name Prescription Decision (1998)The Importance of the Physici…Generic Entry and the Pricing of Pharmaceuticals (1997)Generic Entry and the Pricing…Parallel imports, demand dispersion, and international price discrimination (1994)Parallel imports, demand disp…Patent Expiration, Entry, and Competition in the U.S. Pharmaceutical Industry (1991)Patent Expiration, Entry, and…Optimal Patent Length and Breadth (1990)Optimal Patent Length and Bre…A Contribution to the Theory of Taxation (1927)A Contribution to the Theory …Increasing Returns and Long-Run Growth (1986)On the mechanics of economic development (1988)The Theory of Economic Development (2003)Beyond the Data Deluge (2009)Recent Research on the Economics of Patents (2012)Global Entrepreneurship Monitor (2002)Misery Loves Companies: Rethinking Social Initiatives by Business (2003)World Development Report 2004 : making services work for poor people (2003)Social entrepreneurship research: A source of explanation, prediction, and delight (2005)Business models for sustainable innovation: state-of-the-art and steps towards a research agenda (2012)Social Enterprises as Hybrid Organizations: A Review and Research Agenda (2014)Measuring security price performance (1980)The Patent Paradox Revisited: An Empirical Study of Patenting in the U.S. Semiconductor Industry, 1979-1995 (2001)The influence of regulations on innovation: A quantitative assessment for OECD countries (2011)Which institutions encourage entrepreneurial growth aspirations? (2012)What Affects Innovation More: Policy or Policy Uncertainty? (2017)The Problem of Social Cost (1960)Endogenous Technological Change (1989)Econometric Analysis of Cross Section and Panel Data (2001)Intellectual Property Rights Protection, Ownership, and Innovation: Evidence from China (2017)A Toolkit of Policies to Promote Innovation (2019)Digital Economics (2019)The optimum life of a patent : reply (1972)How Broad Should the Scope of Patent Protection Be? (1990)Standing on the Shoulders of Giants: Cumulative Research and the Patent Law (1991)The Importance of Patent Scope: An Empirical Analysis (1994)Industrial Market Structure and Economic Performance. (1971)The Theory of Economic Regulation (1971)The Choice between Formal and Informal Intellectual Property: A Review (2014)Foreign Competition and Domestic Innovation: Evidence from US Patents (2020)The Theory of Economic Regulation (2021)Free Entry and Social Inefficiency (1986)Estimation of a Model of Entry in the Airline Industry (1992)Automobile Prices in Market Equilibrium (1995)What do we know about entry? (1995)An empirical analysis of sustained advantage in the U.S. pharmaceutical industry: impact of firm resources and capabilities (1999)The Theory of Incentives: The Principal-Agent Model (2001)Signaling in Retrospect and the Informational Structure of Markets (2002)Salience and Taxation: Theory and Evidence (2009)THE WORLD MEDICINES SITUATION 2011 (2011)The Economic Costs of Type 2 Diabetes: A Global Systematic Review (2015)Essential medicines for universal health coverage (2016)Health insurance and the demand for medical care: evidence from a randomized experiment. (1987)Understanding and Mitigating Uncertainty in Online Exchange Relationships: A Principal–Agent Perspective1 (2007)
this work references cited by second hop

References

  • 2003UNCERTAINTY AND THE WELFARE ECONOMICS OF MEDICAL CARE4,128 cited
  • 1927A Contribution to the Theory of Taxation2,967 cited
  • 2004Social entrepreneurship: Creating new business models to serve the poor1,232 cited
  • 2008Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis926 cited
  • 2008Against Intellectual Monopoly921 cited
  • 1990Optimal Patent Length and Breadth847 cited
  • 2013Intellectual Property Rights and Innovation: Evidence from the Human Genome508 cited
  • 2012The Case Against Patents435 cited
  • 2009The Empirical Impact of Intellectual Property Rights on Innovation: Puzzles and Clues418 cited
  • 1991Patent Expiration, Entry, and Competition in the U.S. Pharmaceutical Industry399 cited
  • 1997Generic Entry and the Pricing of Pharmaceuticals388 cited
  • 2003Differential Pricing for Pharmaceuticals: Reconciling Access, R&D and Patents317 cited
  • 1998The Importance of the Physician in the Generic versus Trade-Name Prescription Decision300 cited
  • 2007Physician Awareness of Drug Cost: A Systematic Review292 cited
  • 1994Parallel imports, demand dispersion, and international price discrimination

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

275 cited
  • 2012Evergreening, patent challenges, and effective market life in pharmaceuticals262 cited
  • Cited by

    No citing works inside the corpus for this window.